Back to MORGAN STANLEY MORGAN STANLEY

PRQRPRQR
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in PROQR THRAPEUTICS N V

MORGAN STANLEY holds 1.8M shares of PRQR (PROQR THRAPEUTICS N V), worth $3.3M as of 2026-Q2. The position was increased (+36.0% shares). PRQR represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$3.3M

Current Shares

1.8M

Total Value Change

+$3.2M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+36.0%
$3.3M0.0%$1.86
34
2026-Q1
Decreased
1.3M
-4.9%
$2.1M0.0%$1.50
0
2025-Q4
Decreased
1.4M
-52.9%
$2.8M0.0%$2.00
0
2025-Q3
Decreased
2.9M
-5.9%
$6.2M0.0%$2.19
0
2025-Q2
Increased
3.1M
+122.9%
$6.3M0.0%$2.04
44
2025-Q1
Increased
1.4M
+184.7%
$1.8M0.0%$1.40
42
2024-Q4
Increased
485,985
+77.1%
$1.3M0.0%$2.65
38
2024-Q3
Increased
274,450
+252.1%
$499,4990.0%$1.83
26
2024-Q2
First report
77,942
-
$129,3840.0%$1.66
0

Other major holders of PRQR: ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used